7 Biggest Mid-Day Losers For Tuesday By: Benzinga via Benzinga June 28, 2016 at 12:59 PM EDT Regulus Therapeutics Inc (NASDAQ: RGLS) shares dropped 45.6 percent to $2.72 after the FDA said it had placed the ... Read More >> Related Stocks: Babcock & Wilcox Enterprises Celyad Sa ADR Comscore Inc Dow Chemical Regulus Therapeutics